Anbio Biotechnology Current Assets
Anbio Biotechnology (NNNN) had Current Assets of $30.24 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-04-07
- 2025-12-31: Assets, Current $30.24M.
- 2024-12-31: Assets, Current $18.53M.
- 2023-12-31: Assets, Current $15.75M.
| Period end | Assets, Current |
|---|---|
| 2025-12-31 | $30.24M 20-F · filed 2026-04-07 |
| 2024-12-31 | $18.53M 20-F · filed 2026-04-07 |
| 2023-12-31 | $15.75M 20-F · filed 2025-04-28 |